Decibel Therapeutics, Inc.
USD4.91
-0.04 (-0.81%)
CEO
Laurence E. Reid
IPO Date
2021-02-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.92
Prev. Close
$4.95
Day Low
$4.90
Day High
$5.09
52W Low
$1.61
52W High
$5.40
Market Cap
$0.12B
Volume
1.06M
| -2.0 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 23.1% | -55.9% | -0.00 | 2.98 | -11.1 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -260.4% | -96.3% | 0.00 | 3.55 | -3.2 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -62.9% | -38.8% | 0.00 | 7.60 | -3.6 |
| -1.4 |
| 31 Dec 2022 | Q4 | 0.0% | 0.0% | -19.5% | -12.9% | 0.17 | 4.81 | -0.8 |
| 30 Sept 2022 | Q3 | 0.0% | 0.0% | -16.5% | -11.2% | 0.15 | 5.40 | -1.3 |
| 30 Jun 2022 | Q2 | 0.0% | 0.0% | -15.2% | -10.8% | 0.14 | 6.18 | -1.5 |
| 31 Mar 2022 | Q1 | 0.0% | 0.0% | -10.9% | -8.1% | 0.12 | 8.35 | -1.4 |
| 31 Dec 2021 | Q4 | 0.0% | 0.0% | -9.1% | -7.0% | 0.00 | 7.99 | -2.2 |
| 30 Sept 2021 | Q3 | 0.0% | 0.0% | -10.6% | -8.9% | 0.00 | 9.08 | -2.9 |
| 30 Jun 2021 | Q2 | 0.0% | 0.0% | -6.9% | -5.9% | 0.00 | 9.70 | -4.6 |
| 31 Mar 2021 | Q1 | 0.0% | 0.0% | -6.0% | -5.2% | 0.00 | 12.56 | -6.3 |